Charles River Laboratories International, Inc.

Charles River Laboratories Beats on EPS, Stock Down 0.15%

Charles River Laboratories reported an EPS of $0.79, exceeding expectations by 7.78%. However, the stock reacted slightly negatively, declining by 0.15%. The lack of revenue data and management commentary may have contributed to the muted stock performance.